公开(公告)号：US11813323B2

公开(公告)日：2023-11-14

申请号：US17849392

申请日：2022-06-24

Applicant: GLAXOSMITHKLINE BIOLOGICALS SA

Inventor： Philip Dormitzer

IPC: A61K39/155 ,  A61K39/12 ,  A61P31/14 ,  A61K39/00

CPC classification number: A61K39/155 ,  A61K39/12 ,  A61P31/14 ,  A61K2039/545 ,  A61K2039/55 ,  C12N2760/18634

Abstract: The invention relates to an immunization regimen whereby an infant is protected against respiratory syncytial virus (RSV) through administration of a first anti-RSV immune response inducing composition to his or her mother during pregnancy, followed by administration of a second anti-RSV immune response inducing composition to the infant after birth.